BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 20405727)

  • 1. [Characteristics of proliferation and differentiation of cambial and daughter cells in morphofunctional zones in the normal epithelium and cancer using age aspect].
    Iavisheva TM; Shcherbakov SD
    Adv Gerontol; 2009; 22(4):605-13. PubMed ID: 20405727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peculiarities of proliferation and differentiation of cambial and daughter cells of epidermal-dermal morphofunctional zone in normal epithelium and in cancer.
    Yavisheva TM; Shcherbakov SD
    Bull Exp Biol Med; 2010 Oct; 149(4):521-6. PubMed ID: 21234456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Melanoma and cancer emergence in persons of 20-60 years against normal quantity of cambial cells in morphofunctional zones].
    Iavisheva TM; Shchebakov SD
    Adv Gerontol; 2014; 27(4):753-7. PubMed ID: 25946855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-specific morphofunctional changes in cambial cells and their derivatives in human skin.
    Yavisheva TM; Shcherbakov SD
    Bull Exp Biol Med; 2009 Sep; 148(3):437-40. PubMed ID: 20396707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Participation of morphofunctional zones in aging processes].
    Iavisheva TM; Shcherbakov SD
    Adv Gerontol; 2012; 25(4):604-11. PubMed ID: 23734504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of the work of morphofunctional zones in normal epithelium, fibroadenoma, and cancer of the breast.
    Yavisheva TM; Shcherbakov SD; Golubeva IS; Savluchinskaya LA
    Bull Exp Biol Med; 2005 Aug; 140(2):231-4. PubMed ID: 16283009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of cambial dermal cells (fibroblasts) and epidermis in morphofunctional area of mouse skin.
    Yavisheva TM; Shcherbakov SD; Golubeva IS; Sharafutdinov GZ
    Bull Exp Biol Med; 2007 Nov; 144(5):748-53. PubMed ID: 18683514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural organization of the basal layer and morphofunctional characteristics of mouse epidermal cambial cells.
    Yavisheva TM; Shcherbakov SD; Golubeva IS; Sharafutdinov GZ; Savluchinskaya LA
    Bull Exp Biol Med; 2004 May; 137(5):513-6. PubMed ID: 15455132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the common mechanisms of cambial somatic and sex cells proliferation and the notion of the cambial cells.
    Yavisheva TM; Shcherbakov SD
    Bull Exp Biol Med; 2012 May; 153(1):82-5. PubMed ID: 22808500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Src homology 2 domain substitution modulates the kinase and transforming activities of the Fes protein-tyrosine kinase.
    Rogers JA; Cheng HY; Smithgall TE
    Cell Growth Differ; 2000 Nov; 11(11):581-92. PubMed ID: 11095247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SH4-Unique-SH3-SH2 domains dictate specificity in signaling that differentiate c-Yes from c-Src.
    Summy JM; Qian Y; Jiang BH; Guappone-Koay A; Gatesman A; Shi X; Flynn DC
    J Cell Sci; 2003 Jun; 116(Pt 12):2585-98. PubMed ID: 12734402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SH3-dependent stimulation of Src-family kinase autophosphorylation without tail release from the SH2 domain in vivo.
    Lerner EC; Smithgall TE
    Nat Struct Biol; 2002 May; 9(5):365-9. PubMed ID: 11976726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The small peptide OGP(10-14) acts through Src kinases and RhoA pathways in Mo-7e cells: morphologic and immunologic evaluation.
    Mattii L; Battolla B; Moscato S; Fazzi R; Galimberti S; Bernardini N; Dolfi A; Petrini M
    Med Sci Monit; 2008 Jun; 14(6):BR103-108. PubMed ID: 18509267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in binding of PI 3-kinase to the src-homology domains 2 and 3 of p56 lck and p59 fyn tyrosine kinases.
    Susa M; Rohner D; Bichsel S
    Biochem Biophys Res Commun; 1996 Mar; 220(3):729-34. PubMed ID: 8607833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SH3 and SH2 domains are capable of directing specificity in protein interactions between the non-receptor tyrosine kinases cSrc and cYes.
    Summy JM; Guappone AC; Sudol M; Flynn DC
    Oncogene; 2000 Jan; 19(1):155-60. PubMed ID: 10644991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperative activation of Src family kinases by SH3 and SH2 ligands.
    Yadav SS; Miller WT
    Cancer Lett; 2007 Nov; 257(1):116-23. PubMed ID: 17719722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of CENP-V as a novel microtubule-associating molecule that activates Src family kinases through SH3 domain interaction.
    Honda Z; Suzuki T; Honda H
    Genes Cells; 2009 Dec; 14(12):1383-94. PubMed ID: 19930468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding, domain orientation, and dynamics of the Lck SH3-SH2 domain pair and comparison with other Src-family kinases.
    Hofmann G; Schweimer K; Kiessling A; Hofinger E; Bauer F; Hoffmann S; Rösch P; Campbell ID; Werner JM; Sticht H
    Biochemistry; 2005 Oct; 44(39):13043-50. PubMed ID: 16185072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of the linker between the SH2 domain and catalytic domain in the regulation and function of Src.
    Gonfloni S; Williams JC; Hattula K; Weijland A; Wierenga RK; Superti-Furga G
    EMBO J; 1997 Dec; 16(24):7261-71. PubMed ID: 9405355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel mechanism of regulation of the non-receptor protein tyrosine kinase Csk: insights from NMR mapping studies and site-directed mutagenesis.
    Shekhtman A; Ghose R; Wang D; Cole PA; Cowburn D
    J Mol Biol; 2001 Nov; 314(1):129-38. PubMed ID: 11724538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.